Biosimilars Cut Cancer Drug Costs by Nearly $4,000 a Month for Insurers, UCLA Study Shows
A UCLA-led analysis of more than 14,000 patient-drug pairs published in JAMA Oncology found that exclusive biosimilar use was associated ...
Tag: JAMA Oncology
MRI Before Prostate Biopsy Surges Nationwide as New Evidence Reshapes Care
A new national study of more than 505,000 prostate biopsies finds prebiopsy MRI use surged from 14 percent in 2017 ...
Five-Year Data Confirm Lasting Benefit of Pembrolizumab Chemotherapy Combo in Cervical Cancer
Five-year results from the KEYNOTE-826 trial confirm that adding pembrolizumab to first-line chemotherapy delivers durable survival benefit for patients with ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!